Nicholas Stewart  Green net worth and biography

Nicholas Green Biography and Net Worth

Nicholas Green currently serves as President & CEO of Avid Bioservices and previously served in senior executive roles for several contract manufacturing organizations and life sciences companies, including President & CEO of Therapure Biopharma and Evolve Biologics, Managing Director of Nipa Laboratories Ltd, Head of the Life Sciences Division of Clariant International Ltd, President and CEO of Rhodia Pharma Solutions and President of Codexis Pharma Division. Up until recently Mr. Green was also a Board Member at Induce Biologics Inc and Redrock Regeneration.
Mr. Green holds a BSc (Hons) in chemistry from Queen Mary University of London and an MBA from the University of Huddersfield in the UK. He has more than 30 years of experience in the global pharmaceutical and healthcare services industry with significant expertise in the contract manufacturing of novel pharmaceutical products. His global pharmaceutical experience spans four continents, having run 31 facilities in nine countries spanning North America, South America, Europe, and Asia.

What is Nicholas Stewart Green's net worth?

The estimated net worth of Nicholas Stewart Green is at least $1.07 million as of July 31st, 2023. Mr. Green owns 145,844 shares of Avid Bioservices stock worth more than $1,067,578 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Green may own. Additionally, Mr. Green receives an annual salary of $1,350,000.00 as CEO at Avid Bioservices. Learn More about Nicholas Stewart Green's net worth.

How old is Nicholas Stewart Green?

Mr. Green is currently 59 years old. There are 3 older executives and no younger executives at Avid Bioservices. Learn More on Nicholas Stewart Green's age.

What is Nicholas Stewart Green's salary?

As the CEO of Avid Bioservices, Inc., Mr. Green earns $1,350,000.00 per year. Learn More on Nicholas Stewart Green's salary.

How do I contact Nicholas Stewart Green?

The corporate mailing address for Mr. Green and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Nicholas Stewart Green's contact information.

Has Nicholas Stewart Green been buying or selling shares of Avid Bioservices?

Nicholas Stewart Green has not been actively trading shares of Avid Bioservices in the last ninety days. Most recently, Nicholas Stewart Green sold 19,519 shares of the business's stock in a transaction on Monday, July 31st. The shares were sold at an average price of $12.99, for a transaction totalling $253,551.81. Following the completion of the sale, the chief executive officer now directly owns 145,844 shares of the company's stock, valued at $1,894,513.56. Learn More on Nicholas Stewart Green's trading history.

Who are Avid Bioservices' active insiders?

Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.

Are insiders buying or selling shares of Avid Bioservices?

In the last twelve months, Avid Bioservices insiders bought shares 2 times. They purchased a total of 43,000 shares worth more than $325,380.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 21 times. They sold a total of 127,055 shares worth more than $1,756,698.91. The most recent insider tranaction occured on January, 12th when insider Matthew R Kwietniak sold 274 shares worth more than $1,854.98. Insiders at Avid Bioservices own 2.4% of the company. Learn More about insider trades at Avid Bioservices.

Information on this page was last updated on 1/12/2024.

Nicholas Stewart Green Insider Trading History at Avid Bioservices

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/31/2023Sell19,519$12.99$253,551.81145,844View SEC Filing Icon  
7/10/2023Sell7,530$13.77$103,688.10127,863View SEC Filing Icon  
6/29/2023Sell40,856$12.70$518,871.20120,067View SEC Filing Icon  
4/13/2023Sell7,000$20.92$146,440.0083,531View SEC Filing Icon  
4/10/2023Sell7,598$19.80$150,440.4090,531View SEC Filing Icon  
1/10/2023Sell8,100$14.44$116,964.0083,729View SEC Filing Icon  
10/10/2022Sell7,493$17.90$134,124.7076,615View SEC Filing Icon  
8/1/2022Sell19,058$19.22$366,294.7669,708View SEC Filing Icon  
7/11/2022Sell2,939$17.75$52,167.2551,266View SEC Filing Icon  
7/8/2022Sell22,725$17.53$398,369.2548,632View SEC Filing Icon  
4/11/2022Sell2,939$18.56$54,547.8428,103View SEC Filing Icon  
1/10/2022Sell3,214$21.58$69,358.12View SEC Filing Icon  
10/11/2021Sell2,786$22.37$62,322.82View SEC Filing Icon  
8/2/2021Sell18,701$25.56$477,997.5638,553View SEC Filing Icon  
See Full Table

Nicholas Stewart Green Buying and Selling Activity at Avid Bioservices

This chart shows Nicholas Stewart Green's buying and selling at Avid Bioservices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avid Bioservices Company Overview

Avid Bioservices logo
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Read More

Today's Range

Now: $7.32
Low: $6.71
High: $7.40

50 Day Range

MA: $7.01
Low: $6.09
High: $8.79

2 Week Range

Now: $7.32
Low: $4.07
High: $18.86

Volume

1,916,070 shs

Average Volume

892,116 shs

Market Capitalization

$462.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.63